Pharmacological inhibition of dynamin II reduces constitutive protein secretion from primary human macrophages

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Kockx, Maaike ^a   Karunakaran, Denuja ^b,c   Traini, Mathew ^a   Xue, Jing ^a   Huang, Kuan Yen ^b   Nawara, Diana ^a   Gaus, Katharina ^b   Jessup, Wendy ^a   Robinson, Phillip J ^a   Kritharides, Leonard ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^d ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CELL PROTEIN; CHITINASE 3 LIKE PROTEIN 1; CYCLOPHILIN A; DYNAMIN II; FIBRONECTIN; GELATINASE B; GUANOSINE TRIPHOSPHATASE; ISOPROTEIN; LYSOZYME; MESSENGER RNA; PROTEIN DERIVATIVE; PROTEIN DYNGO; PROTEIN DYNOLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 2-CYANO-N-OCTYL-3-(1-(3-DIMETHYLAMINOPROPYL)-1H-INDOL-3-YL)ACRYLAMIDE; ACRYLAMIDE DERIVATIVE; INDOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LIPOPROTEIN SECRETION; MACROPHAGE; MICROTUBULE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; EXOCYTOSIS; GENETICS; HAMSTER; HEPG2 CELL LINE; METABOLISM; SECRETORY PATHWAY;

ACRYLAMIDES; ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DYNAMIN II; EXOCYTOSIS; HEP G2 CELLS; HUMANS; INDOLES; MACROPHAGES; SECRETORY PATHWAY;

EID: 84908647089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111186     Document Type: Article

References (48)

1. Cao H, Garcia F, McNiven MA (1998) Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell 9: 2595-2609.
2. Cook TA, Urrutia R, McNiven MA (1994) Identification of dynamin 2, an isoform ubiquitously expressed in rat tissues. Proc Natl Acad Sci USA 91: 644-648.
3. Praefcke GJK, McMahon HT (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5: 133-147.
4. Jones SM, Howell KE, Henley J.R., Cao H., McNiven MA (1998) Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 279: 573-577.
5. Liu Y-W, Surka M.C., Schroeter T., Lukiyanchuk V, Schmid SL (2008) Isoform and splice-variant specific functions of dynamin-2 revealed by analysis of conditional knock-out cells. Mol Biol Cell 19: 5347-5359.
6. Kasai K, Shin HW, Shinotsuka C, Murakami K., Nakayama K (1999) Dynamin II is involved in endocytosis but not in the formation of transport vesicles from the trans-Golgi network. J Biochem 125: 780-789.
7. Altschuler Y, Barbas SM, Terlecky L.J., Tang K., Hardy S, et al. (1998) Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol 143: 1871-1881.
8. Weller SG, Capitani M, Cao H., Micaroni M, Luini A, et al. (2010) Src kinase regulates the integrity and function of the Golgi apparatus via activation of dynamin 2. Proc Natl Acad Sci USA 107: 5863-5868.
9. Bonazzi M, Spanò S, Turacchio G, Cericola C, Valente C, et al. (2005) CtBP3/BARS drives membrane fission in dynamin-independent transport pathways. Nat Cell Biol 7: 570-580.
10. Hill TA, Odell LR, Quan A, Abagyan R., Ferguson G, et al. (2004) Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity. Bioorganic & Medicinal Chemistry Letters 14: 3275-3278.
11. Quan A, McGeachie AB, Keating D.J., van Dam EM, Rusak J, et al. (2007) Myristyl Trimethyl Ammonium Bromide and Octadecyl Trimethyl Ammonium Bromide Are Surface-Active Small Molecule Dynamin Inhibitors that Block Endocytosis Mediated by Dynamin I or Dynamin II. Molecular Pharmacology 72: 1425-1439.
12. Macia E, Ehrlich M, Massol R., Boucrot E, Brunner C, et al. (2006) Dynasore, a Cell-Permeable Inhibitor of Dynamin. Dev Cell 10: 839-850.
13. McCluskey A, Daniel JA, Hadzic G, Chau N., Clayton EL, et al. (2013) Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic 14: 1272-1289.
14. Hill TA, Gordon CP, McGeachie A.B., Venn-Brown B, Odell LR, et al. (2009) Inhibition of dynamin mediated endocytosis by the dynoles-synthesis and functional activity of a family of indoles. J Med Chem 52: 3762-3773.
15. Sadowski L, Jastrzębski K, Kalaidzidis Y., Heldin C-H, Hellberg C, et al. (2013) Dynamin Inhibitors Impair Endocytosis and Mitogenic Signaling of PDGF. Traffic.
16. Harper CB, Martin S, Nguyen T.H., Daniels SJ, Lavidis NA, et al. (2011) Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem 286: 35966-35976.
17. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
18. Kockx M, Jessup W, Kritharides L (2008) Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler Thromb Vasc Biol 28: 1060-1067.
19. Ly S, Altman R, Petrlova J., Lin Y, Hilt S, et al. (2013) Binding of apolipoprotein E inhibits the oligomer growth of amyloid-b peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem 288: 11628-11635.
20. Berbée JFP, Havekes LM, Rensen PCN (2005) Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11: 97-103.
21. Huang ZH, Reardon CA, Subbaiah P.V., Getz GS, Mazzone T (2013) ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res 54: 202-213.
22. Karunakaran D, Kockx M, Owen D.M., Burnett JR, Jessup W, et al. (2013) Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages. J Biol Chem 288: 5186-5197.
23. Kockx M, Rye K-A, Gaus K, Quinn C.M., Wright J., et al. (2004) Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. J Biol Chem 279: 25966-25977.
24. Kockx M, Guo DL, Traini M, Gaus K., Kay J, et al. (2009) Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway. J Biol Chem 284: 24144-24154. doi:10.1074/jbc.M109.032615.
25. Ferguson SM, Ferguson S, Raimondi A., Paradise S, Shen H, et al. (2009) Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Dev Cell 17: 811-822.
26. Raimondi A, Ferguson SM, Lou X, Armbruster M., Paradise S, et al. (2011) Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron 70: 1100-1114.
27. Kockx M, Dinnes DL, Huang K-Y, Sharpe LJ, Jessup W, et al. (2012) Cholesterol accumulation inhibits ER to Golgi transport and protein secretion: studies of apolipoprotein E and VSVGt. Biochem J 447: 51-60.
28. Lee Y, Kockx M, Raftery M.J., Jessup W., Griffith R, et al. (2010) Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290. Mol Cell Proteomics 9: 1968-1981.
29. Kockx M, Guo DL, Huby T, Lesnik P., Kay J, et al. (2007) Secretion of apolipoprotein E from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network. Circ Res 101: 607-616.
30. de Curtis I, Simons K (1989) Isolation of exocytic carrier vesicles from BHK cells. Cell 58: 719-727.
31. Balch WE, Keller DS (1986) ATP-coupled transport of vesicular stomatitis virus G protein. Functional boundaries of secretory compartments. J Biol Chem 261: 14690-14696.
32. Shpetner HS, Vallee RB (1989) Identification of dynamin, a novel mechano-chemical enzyme that mediates interactions between microtubules. Cell 59: 421-432.
33. Tanabe K, Takei K (2009) Dynamic instability of microtubules requires dynamin 2 and is impaired in a Charcot-Marie-Tooth mutant. J Cell Biol 185: 939-948.
34. Park RJ, Shen H, Liu L., Liu X, Ferguson SM, et al. (2013) Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. J Cell Sci 126: 5305-5312.
35. Gáborik Z, Szaszák M, Szidonya L., Balla B, Paku S, et al. (2001) Beta-arrestin-and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Molecular Pharmacology 59: 239-247.
36. Palazzo A, Ackerman B, Gundersen GG (2003) Cell biology: Tubulin acetylation and cell motility. Nature 421: 230.
37. Pankov R, Yamada KM (2002) Fibronectin at a glance. J Cell Sci 115: 3861-3863.
38. Rohwedder I, Montanez E, Beckmann K., Bengtsson E, Dunér P, et al. (2012) Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med 4: 564-576.
39. Van den Steen PE, Dubois B, Nelissen I., Rudd PM, Dwek RA, et al. (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37: 375-536. doi:10.1080/10409230290771546.
40. Thant AA, Nawa A, Kikkawa F., Ichigotani Y, Zhang Y, et al. (2000) Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis 18: 423-428.
41. Coffman FD (2008) Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci 45: 531-562.
42. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, et al. (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19: 687-694.
43. Takemura R, Werb Z (1984) Secretory products of macrophages and their physiological functions. Am J Physiol 246: C1-C9.
44. Liu H, Zheng F, Li Z., Uribarri J, Ren B, et al. (2006) Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol 169: 303-313.
45. Wang P, Heitman J (2005) The cyclophilins. Genome Biol 6: 226.
46. Jin ZG, Melaragno MG, Liao D.F., Yan C., Haendeler J, et al. (2000) Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87: 789-796.
47. Nigro P, Satoh K, O'Dell MR, Soe NN, Cui Z, et al. (2011) Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 208: 53-66.
48. Coppinger JA, Cagney G, Toomey S., Kislinger T, Belton O, et al. (2004) Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103: 2096-2104.